PerkinElmer Acquires Covaris to Create an Innovation-Led Platform
With the sell-off of its applied science, food and enterprise services businesses now complete, PerkinElmer is charting a new path with its remaining diagnostics and life sciences divisions.
PerkinElmer Board Declares Quarterly Dividend
PerkinElmer to Hold Earnings Call on Thursday, May 11, 2023
There’s a new multi-billion-dollar medtech company in town.
PerkinElmer Completes Divestiture of its Applied, Food and Enterprise Services Businesses
PerkinElmer to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
PerkinElmer Launches EnVison Nexus Multimode Plate Reader to Drive Improved Research and Discovery Workflows
PerkinElmer to Present at Upcoming Investor Conferences
PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2022